• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Differences in the operational characteristics of the human recombinant somatostatin receptor types, sst1 and sst2, in mouse fibroblast (Ltk-) cells.人重组生长抑素受体亚型sst1和sst2在小鼠成纤维细胞(Ltk-)中的操作特性差异。
Br J Pharmacol. 1996 Feb;117(4):639-46. doi: 10.1111/j.1476-5381.1996.tb15238.x.
2
Identification and characterisation of heterogeneous somatostatin binding sites in rat distal colonic mucosa.大鼠远端结肠黏膜中异质性生长抑素结合位点的鉴定与表征
Naunyn Schmiedebergs Arch Pharmacol. 1996 Nov;354(5):543-9. doi: 10.1007/BF00170826.
3
Characterisation of the fish sst3 receptor, a member of the SRIF1 receptor family: atypical pharmacological features.鱼类促生长抑素3受体(SRIF1受体家族成员)的特性:非典型药理学特征
Neuropharmacology. 1999 Mar;38(3):449-62. doi: 10.1016/s0028-3908(98)00179-8.
4
Somatostatin receptors mediating inhibition of basal and stimulated electrogenic ion transport in rat isolated distal colonic mucosa.生长抑素受体介导对大鼠离体远端结肠黏膜基础和刺激后的电生性离子转运的抑制作用。
Naunyn Schmiedebergs Arch Pharmacol. 1995 Oct;352(4):402-11. doi: 10.1007/BF00172777.
5
Somatostatin receptors in the rhesus monkey brain: localization and pharmacological characterization.恒河猴大脑中的生长抑素受体:定位与药理学特性
Naunyn Schmiedebergs Arch Pharmacol. 1996 May;353(6):648-60. doi: 10.1007/BF00167184.
6
Characterisation of human recombinant somatostatin receptors. 2. Modulation of GTPgammaS binding.人重组生长抑素受体的特性。2. GTPγS结合的调节
Naunyn Schmiedebergs Arch Pharmacol. 1999 Nov;360(5):500-9. doi: 10.1007/s002109900142.
7
[125I][Tyr3]octreotide labels human somatostatin sst2 and sst5 receptors.[125I][酪氨酸3]奥曲肽标记人类生长抑素sst2和sst5受体。
Eur J Pharmacol. 1998 May 8;348(2-3):311-20. doi: 10.1016/s0014-2999(98)00159-9.
8
Drug design at peptide receptors: somatostatin receptor ligands.肽受体的药物设计:生长抑素受体配体
J Mol Neurosci. 2002 Feb-Apr;18(1-2):15-27. doi: 10.1385/JMN:18:1-2:15.
9
Characterisation of human recombinant somatostatin receptors. 3. Modulation of adenylate cyclase activity.人重组生长抑素受体的特性。3. 腺苷酸环化酶活性的调节。
Naunyn Schmiedebergs Arch Pharmacol. 1999 Nov;360(5):510-21. doi: 10.1007/s002109900143.
10
Somatostatin receptors in Neuro2A neuroblastoma cells: operational characteristics.Neuro2A神经母细胞瘤细胞中的生长抑素受体:功能特性
Br J Pharmacol. 1997 Jan;120(1):45-51. doi: 10.1038/sj.bjp.0700858.

引用本文的文献

1
The Concise Guide to PHARMACOLOGY 2013/14: G protein-coupled receptors.《2013/14药理学简明指南:G蛋白偶联受体》
Br J Pharmacol. 2013 Dec;170(8):1459-581. doi: 10.1111/bph.12445.
2
Evidence that somatostatin sst2 receptors mediate striatal dopamine release.生长抑素sst2受体介导纹状体多巴胺释放的证据。
Br J Pharmacol. 1999 Nov;128(6):1346-52. doi: 10.1038/sj.bjp.0702934.
3
A specifically radiolabeled somatostatin analog with strong antitumor activity induces apoptosis and accumulates in the cytosol and the nucleus of HT29 human colon carcinoma cells.一种具有强抗肿瘤活性的特异性放射性标记生长抑素类似物可诱导HT29人结肠癌细胞凋亡,并在其细胞质和细胞核中蓄积。
Endocrine. 1999 Feb;10(1):25-34. doi: 10.1385/ENDO:10:1:25.
4
Identification and characterisation of heterogeneous somatostatin binding sites in rat distal colonic mucosa.大鼠远端结肠黏膜中异质性生长抑素结合位点的鉴定与表征
Naunyn Schmiedebergs Arch Pharmacol. 1996 Nov;354(5):543-9. doi: 10.1007/BF00170826.

本文引用的文献

1
Distribution and second messenger coupling of four somatostatin receptor subtypes expressed in brain.大脑中表达的四种生长抑素受体亚型的分布及第二信使偶联
FEBS Lett. 1993 Sep 27;331(1-2):53-9. doi: 10.1016/0014-5793(93)80296-7.
2
Subtype-specific signaling mechanisms of somatostatin receptors SSTR1 and SSTR2.生长抑素受体SSTR1和SSTR2的亚型特异性信号传导机制
J Biol Chem. 1994 Apr 8;269(14):10357-62.
3
Characterization of cloned somatostatin receptors SSTR4 and SSTR5.克隆的生长抑素受体SSTR4和SSTR5的特性分析
Mol Pharmacol. 1993 Aug;44(2):385-92.
4
Cloned somatostatin receptors: identification of subtype-selective peptides and demonstration of high affinity binding of linear peptides.克隆的生长抑素受体:亚型选择性肽的鉴定及线性肽高亲和力结合的证明。
Mol Pharmacol. 1993 Jun;43(6):838-44.
5
Phospholipase C activation and Ca2+ mobilization by cloned human somatostatin receptor subtypes 1-5, in transfected COS-7 cells.克隆的人类生长抑素受体亚型1 - 5在转染的COS - 7细胞中激活磷脂酶C及动员Ca2+
FEBS Lett. 1994 Jul 11;348(2):192-6. doi: 10.1016/0014-5793(94)00603-2.
6
Subtype selectivity of peptide analogs for all five cloned human somatostatin receptors (hsstr 1-5).肽类似物对所有五种克隆的人类生长抑素受体(hsstr 1 - 5)的亚型选择性。
Endocrinology. 1994 Dec;135(6):2814-7. doi: 10.1210/endo.135.6.7988476.
7
Human somatostatin receptor, SSTR2, is coupled to adenylyl cyclase in the presence of Gi alpha 1 protein.人生长抑素受体SSTR2在Giα1蛋白存在的情况下与腺苷酸环化酶偶联。
Biochem Biophys Res Commun. 1994 Jul 29;202(2):1188-95. doi: 10.1006/bbrc.1994.2054.
8
All five cloned human somatostatin receptors (hSSTR1-5) are functionally coupled to adenylyl cyclase.所有五个克隆的人类生长抑素受体(hSSTR1 - 5)在功能上都与腺苷酸环化酶偶联。
Biochem Biophys Res Commun. 1994 Jan 28;198(2):605-12. doi: 10.1006/bbrc.1994.1088.
9
Mediation by SRIF1 receptors of the contractile action of somatostatin in rat isolated distal colon; studies using some novel SRIF analogues.生长抑素在大鼠离体远端结肠收缩作用中通过SRIF1受体介导;使用一些新型生长抑素类似物的研究。
Br J Pharmacol. 1994 Oct;113(2):628-34. doi: 10.1111/j.1476-5381.1994.tb17036.x.
10
Classification and nomenclature of somatostatin receptors.生长抑素受体的分类与命名
Trends Pharmacol Sci. 1995 Mar;16(3):86-8. doi: 10.1016/s0165-6147(00)88988-9.

人重组生长抑素受体亚型sst1和sst2在小鼠成纤维细胞(Ltk-)中的操作特性差异。

Differences in the operational characteristics of the human recombinant somatostatin receptor types, sst1 and sst2, in mouse fibroblast (Ltk-) cells.

作者信息

Castro S W, Buell G, Feniuk W, Humphrey P P

机构信息

Department of Pharmacology, Glaxo Institute of Applied Pharmacology, University of Cambridge.

出版信息

Br J Pharmacol. 1996 Feb;117(4):639-46. doi: 10.1111/j.1476-5381.1996.tb15238.x.

DOI:10.1111/j.1476-5381.1996.tb15238.x
PMID:8646408
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1909325/
Abstract
  1. The human recombinant somatostatin (SRIF) receptors, sst1 and sst2, have been stably expressed in mouse fibroblast (Ltk-) cells. Two stable clones, LSSR 1/20 and LSSR 11/13, expressing sst1 and sst2 receptors, respectively, have been used to characterize these receptor types using radioligand binding assays as well as measurements of changes in extracellular acidification rates using microphysiometry. 2. [125I]-[Tyr11]-SRIF bound to sst1 and sst2 receptors expressed in Ltk- cells with high affinity, Kd values being 1.52 nM, and 0.23 nM respectively. 3. In Ltk- cells expressing sst1 receptors, SRIF, SRIF-28, [D-Trp8]-SRIF and CGP 23996 all displaced [125I]-[Tyr11]-SRIF binding with high potency (IC50 values of 0.43 - 1.27 nM) whilst seglitide, BIM-23027, BIM-23056 and L-362855 were either weak inhibitors of binding or were ineffective. 4. In contrast MK-678 (seglitide) and BIM-23027 were the most potent inhibitors of [125I]-[Tyr11]-SRIF binding in Ltk- cells expressing sst2 receptors with IC50 values of 0.014 and 0.035 nM, respectively. 5. SRIF and a number of SRIF agonists, including seglitide and BIM-23027, caused concentration-dependent increases in extracellular acidification rates in Ltk- cells expressing sst2 receptors but not in Ltk- cells expressing sst1 receptors. The maximum increase in acidification rate produced by SRIF was 11.3 +/- 0.7% above baseline (0.1-0.28 pH unit min-1). The relative potencies of the SRIF agonists examined in causing increases in extracellular acidification rates in Ltk- cells expressing sst2 receptors correlated well with their relative potencies in inhibiting [125I]-[Tyr11] -SRIF binding (r = 0.94). 6. The increase in extracellular acidification produced by SRIF was markedly inhibited by pretreatment of cells with pertussis toxin (100 ng ml-1) indicating the involvement of pertussis toxin-sensitive G proteins. 7. SRIF (1 microM) had no effect on basal cyclic AMP levels in Ltk- cells expressing sst1 or sst2 receptors nor did it inhibit forskolin stimulated increases in cyclic AMP levels in either cell type. 8. The results from the present study describe the operational characteristics of human sst2 receptors expressed in Ltk- cells where receptor activation causes increases in extracellular acidification rates. This receptor is coupled to a pertussis toxin-sensitive G protein. In contrast, activation of sst1 receptors, at a similar transfection density, did not cause increases in extracellular acidification rates.
摘要
  1. 人重组生长抑素(SRIF)受体sst1和sst2已在小鼠成纤维细胞(Ltk-)中稳定表达。两个稳定克隆LSSR 1/20和LSSR 11/13,分别表达sst1和sst2受体,已被用于通过放射性配体结合试验以及使用微生理测定法测量细胞外酸化率的变化来表征这些受体类型。2. [125I]-[Tyr11]-SRIF以高亲和力与Ltk-细胞中表达的sst1和sst2受体结合,Kd值分别为1.52 nM和0.23 nM。3. 在表达sst1受体的Ltk-细胞中,SRIF、SRIF-28、[D-Trp8]-SRIF和CGP 23996均能高效取代[125I]-[Tyr11]-SRIF的结合(IC50值为0.43 - 1.27 nM),而司美格鲁肽、BIM-23027、BIM-23056和L-362855要么是弱结合抑制剂,要么无作用。4. 相比之下,MK-678(司美格鲁肽)和BIM-23027是表达sst2受体的Ltk-细胞中[125I]-[Tyr11]-SRIF结合的最有效抑制剂,IC50值分别为0.014和0.035 nM。5. SRIF和一些SRIF激动剂,包括司美格鲁肽和BIM-23027,可使表达sst2受体的Ltk-细胞中的细胞外酸化率呈浓度依赖性增加,但在表达sst1受体的Ltk-细胞中则无此作用。SRIF产生的酸化率最大增加幅度比基线高11.3 +/- 0.7%(0.1 - 0.28 pH单位/分钟)。在表达sst2受体的Ltk-细胞中,所检测的SRIF激动剂在引起细胞外酸化率增加方面的相对效力与其在抑制[125I]-[Tyr11]-SRIF结合方面的相对效力密切相关(r = 0.94)。6. 用百日咳毒素(100 ng/ml)预处理细胞可显著抑制SRIF产生的细胞外酸化增加,表明百日咳毒素敏感的G蛋白参与其中。7. SRIF(1 microM)对表达sst1或sst2受体的Ltk-细胞中的基础环磷酸腺苷水平无影响,也不抑制两种细胞类型中福斯高林刺激的环磷酸腺苷水平增加。8. 本研究结果描述了在Ltk-细胞中表达的人sst2受体的操作特性,该受体激活会导致细胞外酸化率增加。该受体与百日咳毒素敏感的G蛋白偶联。相比之下,在相似的转染密度下,sst1受体的激活并未导致细胞外酸化率增加。